Drug eluting stents in 2005: have the initial expectations been met?

Drug eluting stent is a new technology aimed to prevent the development of neointimal hyperplasia and restenosis following percutaneous coronary intervention. This review describes the direction for their use at the present time and the future of their utilization with the summary of the principals...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annales de cardiologie et d'angéiologie 2005-11, Vol.54 (6), p.325
Hauptverfasser:	Couppié, P, De Poli, F, Thalouarn, C, Fellinger, F, Hanssen, M, Dickelé, M C
Format:	Artikel
Sprache:	fre
Schlagworte:	Angioplasty, Balloon, Coronary - instrumentation Angioplasty, Balloon, Coronary - methods Clinical Trials as Topic Coated Materials, Biocompatible Coronary Disease - therapy Coronary Restenosis - prevention & control Drug Delivery Systems Humans Immunosuppressive Agents - therapeutic use Paclitaxel - therapeutic use Sirolimus - therapeutic use Stents - trends Tubulin Modulators - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Drug eluting stent is a new technology aimed to prevent the development of neointimal hyperplasia and restenosis following percutaneous coronary intervention. This review describes the direction for their use at the present time and the future of their utilization with the summary of the principals clinicals trials.
ISSN:	0003-3928